NYSE:HQL Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News $12.38 -0.05 (-0.40%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$12.25▼$12.4450-Day Range$12.38▼$13.7152-Week Range$12.25▼$15.30Volume100,113 shsAverage Volume83,357 shsMarket Capitalization$324.48 millionP/E RatioN/ADividend Yield10.34%Price TargetN/A ProfileProfileChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Tekla Life Sciences Investors (NYSE:HQL) StockTekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Read More HQL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQL Stock News HeadlinesSeptember 26, 2023 | americanbankingnews.comTekla Life Sciences Investors (NYSE:HQL) President Daniel R. Omstead Purchases 10,096 Shares of StockSeptember 26, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 10,096 Shares of Tekla Life Sciences ...September 26, 2023 | Chaikin Analytics (Ad)Something is Coming for America's Top StockThis stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.September 21, 2023 | finance.yahoo.comInsider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...August 15, 2023 | seekingalpha.comTekla Life Sciences declares $0.32 dividendJune 20, 2023 | finance.yahoo.comabrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUMMay 17, 2023 | msn.comTekla Life Sciences Investors (HQL) Declares $0.32 DividendMay 15, 2023 | msn.comTekla Life Sciences dividend declines by 3% to $0.32September 26, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.March 21, 2023 | seekingalpha.comHQL Tekla Life Sciences InvestorsNovember 18, 2022 | msn.comTekla Life Sciences: Dividend InsightsNovember 2, 2022 | fool.comTekla Life Sciences Investors (NYSE: HQL)July 14, 2022 | seekingalpha.comHQL: A Biotechnology Equity CEF With No LeverageJune 8, 2022 | news.yahoo.comTekla Looks to Hazy Summer Days for New 'High Summer' Sleepwear CapsuleMay 17, 2022 | seekingalpha.comTekla Life Sciences cuts dividend by 10% to $0.35April 27, 2022 | seekingalpha.comHQL: Buy For The Yield, If You Can Stomach The DepreciationFebruary 11, 2022 | seekingalpha.comTekla Life Sciences Investors: Buy For Steady, Quarterly DividendJanuary 18, 2022 | nasdaq.comTekla Life Sciences Investors Shares Approach 52-Week Low - Market MoverAugust 15, 2021 | forbes.com5 Dividend Funds Yielding Up To 27.2%August 13, 2021 | nasdaq.comTekla Life Sciences Investors Shares Close in on 52-Week High - Market MoverFebruary 17, 2021 | benzinga.comTekla Life Sciences Increases Dividend From $0.40 To $0.43January 9, 2021 | seekingalpha.comTekla Life Sciences Investors: 8% Yield, 7% DiscountDecember 21, 2020 | finance.yahoo.comTekla Life Sciences Investors Declares Cash DistributionNovember 24, 2020 | benzinga.comUnderstanding Tekla Life Sciences's Ex-Dividend DateNovember 16, 2020 | finance.yahoo.comTekla Life Sciences Investors Declares DistributionNovember 9, 2020 | seekingalpha.comHQH: Deep Discount Leads To High YieldMay 15, 2020 | www.nasdaq.comHQL TeklaLife Sciences Investors Common StockSee More Headlines Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address HQL Company Calendar Ex-Dividend for 6/30 Dividend5/24/2023Dividend Payable6/30/2023Ex-Dividend for 9/29 Dividend8/24/2023Today9/25/2023Dividend Payable9/29/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Investment offices, not elsewhere classified Sub-IndustryN/A SectorFinance Current SymbolNYSE:HQL CUSIPN/A CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares26,210,000Free Float23,575,000Market Cap$324.48 million OptionableNot Optionable Beta0.81 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Daniel R. Omstead M.S (Age 70)Ph.D., Principal Exec. Officer, Pres and Trustee Key CompetitorsWestern Asset Emerging Markets Debt FundNYSE:EMDTempleton Dragon FundNYSE:TDFPortman Ridge FinanceNASDAQ:PTMNBNY Mellon High Yield Strategies FundNYSE:DHFOxford Lane CapitalNASDAQ:OXLCView All CompetitorsInsiders & InstitutionsDaniel R OmsteadBought 10,096 shares on 9/25/2023Total: $125,089.44 ($12.39/share)Daniel R OmsteadBought 12,000 shares on 9/20/2023Total: $152,160.00 ($12.68/share)Osaic Holdings Inc.Bought 1,271 shares on 8/21/2023Ownership: 0.290%Thomas J. Herzfeld Advisors Inc.Bought 103,490 shares on 8/16/2023Ownership: 0.395%Stifel Financial CorpSold 4,500 shares on 8/15/2023Ownership: 0.206%View All Insider TransactionsView All Institutional Transactions HQL Stock - Frequently Asked Questions How have HQL shares performed in 2023? Tekla Life Sciences Investors' stock was trading at $14.21 at the beginning of the year. Since then, HQL stock has decreased by 12.9% and is now trading at $12.38. View the best growth stocks for 2023 here. Are investors shorting Tekla Life Sciences Investors? Tekla Life Sciences Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 25,700 shares, an increase of 71.3% from the August 15th total of 15,000 shares. Based on an average trading volume of 92,600 shares, the days-to-cover ratio is presently 0.3 days. View Tekla Life Sciences Investors' Short Interest. How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors? Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, August 15th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.32 per share on Friday, September 29th. This represents a $1.28 annualized dividend and a dividend yield of 10.34%. The ex-dividend date of this dividend is Thursday, August 24th. Read our dividend analysis for HQL. Is Tekla Life Sciences Investors a good dividend stock? Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.28 per share and currently has a dividend yield of 10.30%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HQL. What other stocks do shareholders of Tekla Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY). What is Tekla Life Sciences Investors' stock symbol? Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL." Who are Tekla Life Sciences Investors' major shareholders? Tekla Life Sciences Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.18%), Allspring Global Investments Holdings LLC (1.18%), Cornerstone Advisors LLC (0.98%), Wolverine Asset Management LLC (0.90%), Flagship Harbor Advisors LLC (0.92%) and Raymond James & Associates (0.63%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz. View institutional ownership trends. How do I buy shares of Tekla Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Tekla Life Sciences Investors' stock price today? One share of HQL stock can currently be purchased for approximately $12.38. How much money does Tekla Life Sciences Investors make? Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $324.48 million. How can I contact Tekla Life Sciences Investors? Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577. This page (NYSE:HQL) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tekla Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.